ASP (PPI_H2RA) Study-H2RA Versus PPI for the Prevention of Recurrent UGIB in High-risk Users of Low-dose ASA

NCT01408186 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

264

Enrollment

OTHER

Sponsor class

Conditions

Upper Gastrointestinal Bleeding

Interventions

DRUG: Rabeprazole
DRUG: Famotidine

Sponsor

Chinese University of Hong Kong